Charles River eyes global M&A opportunities, expects to double size in 5 years

Media Coverage
Logo on Charles River headquarters

Outsourcing Pharma

Fueled by increasing investments from biotech, Charles River expects to double the size of its business over the next five years – organically and through M&A – to become a ‘more responsive partner,’ says CEO.

Read the Full Article